MRUS - FDA accepts Merus application for Zeno for lung pancreatic cancer May, 06 2024 04:45 PM Merus N.V. 2024-05-06 16:45:41 ET More on Merus Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement Gilead to invest in Merus as part of a research deal Seeking Alpha’s Quant Rating on Merus Historical earnings data for Merus Financial information for Merus For further details see: FDA accepts Merus application for Zeno for lung, pancreatic cancer